RenovoRx Cash from 2010 to 2026
| RNXT Stock | USD 0.93 0.04 4.12% |
Cash | First Reported 2020-03-31 | Previous Quarter 12.3 M | Current Value 10 M | Quarterly Volatility 5.6 M |
Check RenovoRx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among RenovoRx's main balance sheet or income statement drivers, such as Net Interest Income of 463.7 K, Interest Income of 64.3 K or Depreciation And Amortization of 5.1 K, as well as many indicators such as Price To Sales Ratio of 567, Dividend Yield of 0.0 or PTB Ratio of 14.83. RenovoRx financial statements analysis is a perfect complement when working with RenovoRx Valuation or Volatility modules.
RenovoRx | Cash | Build AI portfolio with RenovoRx Stock |
The evolution of Cash for RenovoRx provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how RenovoRx compares to historical norms and industry peers.
Latest RenovoRx's Cash Growth Pattern
Below is the plot of the Cash of RenovoRx over the last few years. Cash refers to the most liquid asset of RenovoRx, which is listed under current asset account on RenovoRx balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from RenovoRx customers. The amounts must be unrestricted with restricted cash listed in a different RenovoRx account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. RenovoRx's Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in RenovoRx's overall financial position and show how it may be relating to other accounts over time.
| Cash | 10 Years Trend |
|
Cash |
| Timeline |
RenovoRx Cash Regression Statistics
| Arithmetic Mean | 3,811,985 | |
| Geometric Mean | 2,920,822 | |
| Coefficient Of Variation | 93.85 | |
| Mean Deviation | 2,557,156 | |
| Median | 2,104,000 | |
| Standard Deviation | 3,577,586 | |
| Sample Variance | 12.8T | |
| Range | 14M | |
| R-Value | 0.51 | |
| Mean Square Error | 10.2T | |
| R-Squared | 0.26 | |
| Significance | 0.04 | |
| Slope | 358,142 | |
| Total Sum of Squares | 204.8T |
RenovoRx Cash History
Other Fundumenentals of RenovoRx
RenovoRx Cash component correlations
Click cells to compare fundamentals
About RenovoRx Financial Statements
RenovoRx shareholders use historical fundamental indicators, such as Cash, to determine how well the company is positioned to perform in the future. Although RenovoRx investors may analyze each financial statement separately, they are all interrelated. The changes in RenovoRx's assets and liabilities, for example, are also reflected in the revenues and expenses on on RenovoRx's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for RenovoRx Stock Analysis
When running RenovoRx's price analysis, check to measure RenovoRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovoRx is operating at the current time. Most of RenovoRx's value examination focuses on studying past and present price action to predict the probability of RenovoRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovoRx's price. Additionally, you may evaluate how the addition of RenovoRx to your portfolios can decrease your overall portfolio volatility.